These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 10730886)
1. Monitoring of residual disease in non-Hodgkin's lymphomas by quantitative PCR (preliminary report). Slavícková A; Ullmannová V; Benesová E; Klener P Folia Biol (Praha); 1999; 45(5):179-83. PubMed ID: 10730886 [TBL] [Abstract][Full Text] [Related]
2. [Semiquantitative monitoring of molecular markers in non-Hodgkin's lymphoma]. Slavícková A; Benesová E; Bradová V; Ullmanová V Cas Lek Cesk; 1997 Apr; 136(7):221-5. PubMed ID: 9221198 [TBL] [Abstract][Full Text] [Related]
3. [Clinical importance of semi-quantitative monitoring of lymphomas using the comparative polymerase chain reaction]. Slavícková A; Ivánek R; Cerný J; Sálková J; Trnĕný M Cas Lek Cesk; 2002 Nov; 141(23):735-8. PubMed ID: 12650030 [TBL] [Abstract][Full Text] [Related]
4. The bcl-2/IgH rearrangement in a population of 204 healthy individuals: occurrence, age and gender distribution, breakpoints, and detection method validity. Schmitt C; Balogh B; Grundt A; Buchholtz C; Leo A; Benner A; Hensel M; Ho AD; Leo E Leuk Res; 2006 Jun; 30(6):745-50. PubMed ID: 16297448 [TBL] [Abstract][Full Text] [Related]
5. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up. Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845 [TBL] [Abstract][Full Text] [Related]
6. Variability of quantitative polymerase chain reaction detection of the bcl-2-IgH translocation in an international multicenter study. Darby AJ; Lanham S; Soubeyran P; Johnson PW Haematologica; 2005 Dec; 90(12):1706-7. PubMed ID: 16330451 [TBL] [Abstract][Full Text] [Related]
7. [Detection of minimal residual diseases in B-cell tumors using PCR specific for the immunoglobulin heavy chain gene]. Matolcsy A; Borbényi Z; Demeter J; Egyed M; Fekete S; Földi J; Gergely L; Kajtár P; Kelényi G; Kiss A; László T; Lehoczky D; Losonczy H; Nagy M; Pál K; Pálóczy K; Radványi G; Semsei I; Varga G; Udvardy M Orv Hetil; 2000 Jun; 141(25):1403-6. PubMed ID: 10934884 [TBL] [Abstract][Full Text] [Related]
8. Combined molecular diagnosis of B-cell lymphomas with t(11;14)(q13;q32) or t(14;18)(q32;q21) using multiplex- and long distance inverse-polymerase chain reaction. Vieira L; Martinho A; Antunes O; Silva E; Ambrósio AP; Geraldes MC; Nascimento R; Silva C; Pereira JM; Júnior EC; Jordan P Diagn Mol Pathol; 2008 Jun; 17(2):73-81. PubMed ID: 18382373 [TBL] [Abstract][Full Text] [Related]
10. A non-isotopic nested polymerase chain reaction method to quantitate minimal residual disease in patients with non-Hodgkin's lymphoma. Hétu F; Coutlée F; Roy DC Mol Cell Probes; 1994 Dec; 8(6):449-57. PubMed ID: 7700265 [TBL] [Abstract][Full Text] [Related]
11. Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations. Böttcher S; Ritgen M; Buske S; Gesk S; Klapper W; Hoster E; Hiddemann W; Unterhalt M; Dreyling M; Siebert R; Kneba M; Pott C; Haematologica; 2008 Apr; 93(4):551-9. PubMed ID: 18379010 [TBL] [Abstract][Full Text] [Related]
12. Detection of minimal residual disease in patients with lymphomas using the polymerase chain reaction. Gribben JG; Nadler LM Important Adv Oncol; 1994; ():117-29. PubMed ID: 8206485 [No Abstract] [Full Text] [Related]
13. Fluorescent polymerase chain reaction and capillary electrophoresis for IgH rearrangement and minimal residual disease evaluation in multiple myeloma. Novella E; Giaretta I; Elice F; Madeo D; Piccin A; Castaman G; Rodeghiero F Haematologica; 2002 Nov; 87(11):1157-64. PubMed ID: 12414345 [TBL] [Abstract][Full Text] [Related]
14. Identification and structural analysis of rearranged immunoglobulin heavy chain genes in lymphomas and leukemias. Linke B; Pyttlich J; Tiemann M; Suttorp M; Parwaresch R; Hiddemann W; Kneba M Leukemia; 1995 May; 9(5):840-7. PubMed ID: 7769847 [TBL] [Abstract][Full Text] [Related]
15. Precast commercial polyacrylamide gels for separation of DNA amplificates by temperature gradient gel electrophoresis: application to clonality analysis of lymphomas. Suttorp M; von Neuhoff N; Tiemann M; Dreger P; Schaub J; Löffer H; Parwaresch R; Schmitz N Electrophoresis; 1996 Apr; 17(4):672-7. PubMed ID: 8738325 [TBL] [Abstract][Full Text] [Related]
16. Real-Time t(14;18)(q32;q21) PCR assay combined with high-resolution capillary electrophoresis: a novel and rapid approach that allows accurate quantitation and size determination of bcl-2/JH fusion sequences. Sanchez-Vega B; Vega F; Hai S; Medeiros LJ; Luthra R Mod Pathol; 2002 Apr; 15(4):448-53. PubMed ID: 11950920 [TBL] [Abstract][Full Text] [Related]
17. Follicular lymphoma: quantitation of minimal residual disease by PCR of the t(14;18) translocation. Darby A; Gribben JG Methods Mol Med; 2005; 115():315-31. PubMed ID: 15998976 [TBL] [Abstract][Full Text] [Related]
18. [Detection of residual disease in follicular lymphomas using the PCR technique: importance of clono-specific probes]. al Saati T; Galoin S; Roda D; Huynh A; Attal M; Delsol G Bull Cancer; 1998 Oct; 85(10):847-54. PubMed ID: 9835862 [TBL] [Abstract][Full Text] [Related]
19. LightCycler-based quantitative real-time PCR monitoring of patients with follicular lymphoma receiving rituximab in combination with conventional or high-dose cytotoxic chemotherapy. Martin S; Fischer C; Free M; Kurreck B; Stockinger H; Fenk R; Arnold C; Kliszewski S; Meckenstock G; Haas R; Kronenwett R Eur J Haematol; 2005 Apr; 74(4):282-92. PubMed ID: 15777339 [TBL] [Abstract][Full Text] [Related]
20. Cytometric detection of DNA amplified with fluorescent primers: applications to analysis of clonal bcl-2 and IgH gene rearrangements in malignant lymphomas. Barker RL; Worth CA; Peiper SC Blood; 1994 Feb; 83(4):1079-85. PubMed ID: 8111048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]